When was Inventage Lab founded?

Inventage Lab was founded in 2015.

Where is Inventage Lab located?

Inventage Lab is headquartered in Seongnam-si, South Korea.

How many employees does Inventage Lab have?

As of Jun 30, 2026, the latest employee count at Inventage Lab is 26.

Is Inventage Lab a funded company?

Inventage Lab is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Inventage Lab rank among its competitors?

Inventage Lab ranks 130th amongst 3119 active competitors, of which 545 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of Inventage Lab?

Inventage Lab's top competitors include WuXi AppTec, Antheia and Transcenta. Among them, Antheia secured the most recent funding round in January, 2026.

Inventage Lab - 2026 Company Profile, Team, Funding & Competitors

Inventage Lab is a public company based in Seongnam-si (South Korea), founded in 2015. It operates as a Developer of a drug delivery system for treating intractable and chronic diseases. The company has 3119 active competitors, including 545 funded and 481 that have exited. Its top competitors include companies like WuXi AppTec, Antheia and Transcenta.

Company Details

Inventage Lab is developing a drug delivery system for treating intractable and chronic diseases. The provide microspheres and related technology for drug delivery.

Website: www.inventagelab.com/en
Social
Email ID: *****@inventagelab.com
Phone Number: +82 **********

Key Metrics

Founded Year

2015

Location

Seongnam-si, South Korea

Stage

Public

Investors

Groom Investment & 9 more

Ranked

130^th among 3119 active competitors

Employee Count

26 as on Jun 30, 2026

Similar Companies

Antheia & 2779 more

Exit Details

Public

View Inventage Lab's full profile

Inventage Lab got listed on Nov 22, 2022.

Click here to take a look at Inventage Lab's IPO in detail

Inventage Lab is a funded company. Inventage Lab has 10 institutional investors.

View details of Inventage Lab's funding rounds and investors

Inventage Lab's employee count trend

Inventage Lab has 26 employees as of Jun 26. Here is Inventage Lab's employee count trend over the years:

Uncover Inventage Lab's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Inventage Lab include WuXi AppTec, Antheia and Transcenta. Here is the list of Top 10 competitors of Inventage Lab, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	WuXi AppTec 2000, Shanghai (China), Public	Provider of CRO and CDMO services	$40M	Synergis Capital, HongShan & 27 others	79/100
2nd	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
3rd	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Sequoia Capital & 11 others	66/100
4th	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Orbimed, Sino Biopharmaceutical & 18 others	65/100
5th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Fidelity Investments ... & 14 others	64/100
6th	ANI Pharmaceuticals 1996, Baudette (United States), Public	Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets	-	Ampersand Capital, US Bank & 4 others	64/100
7th	Fermentalg 2005, Libourne (France), Public	Innovating with algae for sustainable solutions in nutrition and environmental impact	$30.3M	Demeter, Bpifrance & 14 others	63/100
8th	EVERSANA 2014, Milwaukee (United States), Funding Raised	Provider of consulting services for drug pricing access, reimbursement, and regulatory support	-	North Sky Capital, ACE & Company & 2 others	63/100
9th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	UBS, Brown Brothers Harriman & 1 others	63/100
10th	Ipsen 1929, Paris (France), Public	Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes	-	Digital Pharma Lab, Qualium Investissement ... & 2 others	63/100
130th	Inventage Lab 2015, Seongnam-si (South Korea), Public	Developer of a drug delivery system for treating intractable and chronic diseases	-	Groom Investment, STIC Ventures & 8 others	49/100